Dipna Pharmachem Fair Value

Fair Value Analysis Export

P/E Based Valuation

Current EPS ₹1.0
Sector Avg P/E -33.67
Historical Avg P/E N/A
Average Fair Value
₹17.5

P/B Based Valuation

Book Value/Share ₹23.85
Sector Avg P/B 4.14
Historical Avg P/B N/A
Average Fair Value
₹67.25

Asset-Based Valuation

Book Value/Share ₹23.85
Liquidation Value/Share ₹55.46
Fair Value
₹23.85

Benjamin Graham Number

Current EPS ₹1.0
Book Value/Share ₹23.85
Graham Multiplier 22.5
Current P/E 4.5
Graham Criteria 2/3
Graham Number
₹23.16
Criteria Met: P/E ≤ 15, P/B ≤ 1.5

DPL Fair Value Analysis — Data Sources & Coverage

Dipna Pharmachem financial data sources, valuation methods applied and sector benchmarks used. Analyse Dipna Pharmachem shareholding analysis to track promoter, FII and institutional holdings.

Methods Used
4
Sector
Healthcare

Available Data Sources: Financial statements, balance sheet data , sector comparisons.

DPL vs Healthcare Sector Peers — P/E, P/B & Market Cap

Dipna Pharmachem P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.

Company Symbol P/E Ratio P/B Ratio Market Cap (₹ Cr)
Pharmaids Pharmaceuticals PHARMAID -28.7 2.2 ₹100
Modern Diagnostic & Rese… MDRC - 1.42 ₹83
Broach Lifecare Hospital BROACH 90.7 0.82 ₹8
Emcure Pharmaceuticals EMCURE 40.6 8.3 ₹44,381
Glen Industries GLEN 15.7 1.97 ₹250

Important Disclaimer

This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.

This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.

Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.